Armata Pharmaceuticals, Inc.   Report issue

For profit Phase 2
Founded: Marina Del Rey CA United States (2005)

Organization Overview

First Clinical Trial
2020
NCT04596319
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Armata Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

anti-staphylococcus bacteriophage therapy (1 trial)

ap-pa02 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Infections (Phase 2)

Pseudomonas Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2